BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36161964)

  • 1. Human papillomavirus self-testing among unscreened and under-screened Māori, Pasifika and Asian women in Aotearoa New Zealand: A preference survey among responders and interviews with clinical-trial nonresponders.
    Sherman SM; Brewer N; Bartholomew K; Bromhead C; Crengle S; Cunningham C; Douwes J; Foliaki S; Grant J; Maxwell A; McPherson G; Scott N; Wihongi H; Potter JD
    Health Expect; 2022 Dec; 25(6):2914-2923. PubMed ID: 36161964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
    Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and acceptability of telehealth and contactless delivery of human papillomavirus (HPV) self-testing for cervical screening with Māori and Pacific women in a COVID-19 outbreak in Aotearoa New Zealand.
    Bartholomew K; Grant J; Maxwell A; Bromhead C; Gillett F; Saraf R; Moodabe K; Sherman SM; McPherson G; Flower D; Kathuria J; Crengle S; Massey R; Scott N; Coote P
    N Z Med J; 2022 Nov; 135(1565):83-94. PubMed ID: 36356272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Māori and Pasifika women: a pilot study.
    Brewer N; Foliaki S; Bromhead C; Viliamu-Amusia I; Pelefoti-Gibson L; Jones T; Pearce N; Potter JD; Douwes J
    N Z Med J; 2019 Jun; 132(1497):21-31. PubMed ID: 31220062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pasifika women's knowledge and perceptions of cervical-cancer screening and the implementation of self-testing in Aotearoa New Zealand: A qualitative study.
    Brewer N; Foliaki S; Gray M; Potter JD; Douwes J
    Lancet Reg Health West Pac; 2022 Nov; 28():100551. PubMed ID: 35991536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened Indigenous population.
    Adcock A; Cram F; Lawton B; Geller S; Hibma M; Sykes P; MacDonald EJ; Dallas-Katoa W; Rendle B; Cornell T; Mataki T; Rangiwhetu T; Gifkins N; Hart S
    Aust N Z J Obstet Gynaecol; 2019 Apr; 59(2):301-307. PubMed ID: 30614524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Māori women talk about HPV self-testing cervical screening clinical pathways.
    Adcock A; Stevenson K; Cram F; MacDonald EJ; Geller S; Hermens J; Lawton B
    Int J Gynaecol Obstet; 2021 Nov; 155(2):275-281. PubMed ID: 34382217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
    PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
    Brewer N; Bartholomew K; Grant J; Maxwell A; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Foliaki S; Cunningham C; Douwes J; Potter JD
    Lancet Reg Health West Pac; 2021 Nov; 16():100265. PubMed ID: 34590066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial.
    MacDonald EJ; Geller S; Sibanda N; Stevenson K; Denmead L; Adcock A; Cram F; Hibma M; Sykes P; Lawton B
    Aust N Z J Obstet Gynaecol; 2021 Feb; 61(1):135-141. PubMed ID: 33350455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    Fujita M; Nagashima K; Shimazu M; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Hanaoka H; Shozu M; Tsuruoka N; Kasai T; Hata A
    PLoS One; 2023; 18(6):e0286909. PubMed ID: 37289798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary assessment of using mobile point-of-care human papillomavirus (HPV) testing with the option of immediate colposcopy in a rural area in a high-income country: a case study.
    Paterson H; Macfarlane E; Slater T; Stanton JL; MacDonald EJ; Gibson M; Lawton B
    N Z Med J; 2024 Jun; 137(1596):43-51. PubMed ID: 38843549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
    Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
    J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
    Lofters A; Devotta K; Prakash V; Vahabi M
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes towards HPV self-sampling among women in Chengdu, China: A cross-sectional survey.
    He L; He J
    J Med Screen; 2020 Dec; 27(4):201-206. PubMed ID: 31896295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's experience with home-based self-sampling for human papillomavirus testing.
    Sultana F; Mullins R; English DR; Simpson JA; Drennan KT; Heley S; Wrede CD; Brotherton JM; Saville M; Gertig DM
    BMC Cancer; 2015 Nov; 15():849. PubMed ID: 26536865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial.
    Lawton B; MacDonald EJ; Storey F; Stanton JA; Adcock A; Gibson M; Parag V; Sparkes NK; Kaimoana B; King F; Terry M; Watson H; Bennett M; Lambert CS; Geller S; Paasi I; Hibma M; Sykes P; Hawkes D; Saville M
    JMIR Res Protoc; 2023 Sep; 12():e51643. PubMed ID: 37707939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.